Williams C L, Noti J D
Laboratory of Molecular Pharmacology, Guthrie Research Institute, Sayre, PA 18840, USA.
Int J Oncol. 2001 Dec;19(6):1227-33. doi: 10.3892/ijo.19.6.1227.
MCF-7 breast cancer cells stably overexpressing protein kinase C-alpha (MCF-7-PKC-alpha cells) exhibit reduced cell-cell adhesion and increased tumorigenicity in nude mice. We investigated the possibility that alterations in E-cadherin and catenins contribute to the unique phenotype of MCF-7-PKC-alpha cells. Northern and Western blotting indicated that MCF-7-PKC-alpha cells express abnormally low amounts of plakoglobin mRNA and protein, and undetectable levels of E-cadherin mRNA and protein. In contrast, even though MCF-7-PKC-alpha cells express low levels of beta-catenin mRNA, they express undetectable levels of beta-catenin protein, suggesting that post-transcriptional events further diminish beta-catenin expression in these cells. Pulse-labeling of the cells with [35S]methionine showed that the half-life of beta-catenin is less than 15 min in MCF-7-PKC-alpha cells, compared to over 2 h in MCF-7-Vector cells [MCF-7 cells transfected with pSV2M(2)6 vector only]. Incubation with LiCl to inactivate glycogen synthase kinase-3 (GSK-3) significantly prolonged the half-life of beta-catenin in MCF-7-PKC-alpha cells, suggesting that the GSK-3-dependent degradation of beta-catenin contributes to beta-catenin instability in these cells. Northern and Western blotting indicated that Wnt-1, which also inhibits GSK-3 activity, is expressed by MCF-7-Vector cells, but not by MCF-7-PKC-alpha cells. Transfection of (S37A)beta-catenin, which is resistant to GSK-3-dependent degradation, stimulated TCF/LEF-dependent luciferase expression from the pTOPFLASH reporter plasmid by 753-fold in MCF-7-PKC-alpha cells, and by 268-fold in MCF-7-Vector cells. Inactivation of GSK-3 by LiCl stimulated luciferase expression from the pTOPFLASH reporter plasmid by 12.4-fold in MCF-7-PKC-alpha cells, and by 4.8-fold in MCF-7-Vector cells. These results suggest that degradation of beta-catenin by GSK-3 contributes to beta-catenin instability in MCF-7-PKC-alpha cells, diminishing the ability of -catenin to act as a transcriptional co-activator. Reduced Wnt-1 expression by MCF-7-PKC-alpha cells may promote beta-catenin degradation by enhancing GSK-3 activity. Loss of beta-catenin-dependent cell-cell adhesion and transcription may contribute to the aggressive phenotype of MCF-7-PKC-alpha cells.
稳定过表达蛋白激酶C-α的MCF-7乳腺癌细胞(MCF-7-PKC-α细胞)在裸鼠中表现出细胞间黏附减少和致瘤性增加。我们研究了E-钙黏蛋白和连环蛋白的改变是否导致了MCF-7-PKC-α细胞的独特表型。Northern印迹和Western印迹表明,MCF-7-PKC-α细胞中臂蛋白mRNA和蛋白的表达异常低,且检测不到E-钙黏蛋白mRNA和蛋白。相反,尽管MCF-7-PKC-α细胞中β-连环蛋白mRNA表达水平较低,但β-连环蛋白蛋白表达检测不到,这表明转录后事件进一步降低了这些细胞中β-连环蛋白的表达。用[35S]甲硫氨酸对细胞进行脉冲标记显示,与MCF-7-载体细胞(仅用pSV2M(2)6载体转染的MCF-7细胞)中超过2小时相比,MCF-7-PKC-α细胞中β-连环蛋白的半衰期小于15分钟。用LiCl孵育以失活糖原合酶激酶-3(GSK-3)可显著延长MCF-7-PKC-α细胞中β-连环蛋白的半衰期,这表明GSK-3依赖性的β-连环蛋白降解导致了这些细胞中β-连环蛋白的不稳定性。Northern印迹和Western印迹表明,同样抑制GSK-3活性的Wnt-1由MCF-7-载体细胞表达,但不由MCF-7-PKC-α细胞表达。转染对GSK-3依赖性降解具有抗性的(S37A)β-连环蛋白,在MCF-7-PKC-α细胞中刺激了pTOPFLASH报告质粒的TCF/LEF依赖性荧光素酶表达753倍,在MCF-7-载体细胞中刺激了268倍。LiCl使GSK-3失活,在MCF-7-PKC-α细胞中刺激了pTOPFLASH报告质粒的荧光素酶表达12.4倍,在MCF-7-载体细胞中刺激了4.8倍。这些结果表明,GSK-3介导的β-连环蛋白降解导致了MCF-7-PKC-α细胞中β-连环蛋白的不稳定性,降低了β-连环蛋白作为转录共激活因子的能力。MCF-7-PKC-α细胞中Wnt-1表达的降低可能通过增强GSK-3活性促进β-连环蛋白的降解。β-连环蛋白依赖性细胞间黏附及转录的丧失可能导致了MCF-7-PKC-α细胞的侵袭性表型。